glp-1 origin Timeline of discovery and clinical development. (a) Key events in Glucagon-Like Peptide-1: New Regulator in

Has a fiduciary duty to act in the best interests of participants

This study showed that the median time to onset of the overall GLP-1 RA-related AEs was 31 days (IQR = 7145.4 days), which varied among GLP-1 RA regimens

doi: 10.2337/db11-1073

Primarily, there is a significant deficit of human studies evaluating functional aging outcomes rather than just common metabolic indicators, which should include assessments of cognitive ability, physical performance, and physiological resilience

Cardiovascular risk management also appears to be gaining momentum as these agents are increasingly showing benefit in reducing the risk of major cardiovascular events